Skip to main content

Home
Specialties
Resources

Search Videos and More

search

Channel Categories

Breast Cancer (3)
Cancer Screening and Survivorship (3)
Cell Therapy (3)
Gastrointestinal Cancer (4)
Genitourinary Cancer (4)
Gynecologic Oncology (4)
Head and Neck Cancer (4)
Hematologic Oncology (4)
Immunotherapy (3)
Neuro-Oncology (14)
Pediatric Hematology/Oncology (2)
Primary Care (3)
Radiation Oncology (5)
Skin Cancer (3)
Surgical Oncology (2)
Thoracic Cancer (4)
Young Adult Malignancies (2)

Types

News (9)
Video Asset (5)

Showing 1 - 12 of 14 results

Previous| 1 | 2 |Next

World Leaders in Gamma Knife Radiosurgery, Roswell Park Experts Expand Benefits and Access

World Leaders in Gamma Knife Radiosurgery, Roswell Park Experts Expand Benefits and Access

Expertise in Rare Tumor Surgery Neurosurgery: What Sets Roswell Park Apart

Expertise in Rare Tumor Surgery Neurosurgery: What Sets Roswell Park Apart

Roswell Park Researchers to Discuss Recent Discoveries and Critical Issues in Oncology at AACR 2025

Roswell Park Researchers to Discuss Recent Discoveries and Critical Issues in Oncology at AACR 2025

Join Roswell Park's Experts at NCCN

Join Roswell Park's Experts at NCCN

Surgical Options for Treating Acromegaly

Surgical Options for Treating Acromegaly

Congressman Kennedy Announces Over $7.7 Million for State-of-the-Art Biobank at Roswell Park

Congressman Kennedy Announces Over $7.7 Million for State-of-the-Art Biobank at Roswell Park

Roswell Park Experts Provide Nerve Surgery for Pain Relief, Muscle Restoration

Roswell Park Experts Provide Nerve Surgery for Pain Relief, Muscle Restoration

Roswell Park Earns ‘Exceptional’ Rating from National Cancer Institute With Best-Ever Core Grant

Roswell Park Earns ‘Exceptional’ Rating from National Cancer Institute With Best-Ever Core Grant

Clinical Trial of Roswell Park’s SurVaxM Glioblastoma Vaccine Reveals Promising Results

Clinical Trial of Roswell Park’s SurVaxM Glioblastoma Vaccine Reveals Promising Results

Roswell Park Presents ‘Highly Encouraging’ Phase 2A Results on SurVaxM Immunotherapy for Glioblastoma

Roswell Park Presents ‘Highly Encouraging’ Phase 2A Results on SurVaxM Immunotherapy for Glioblastoma

Roswell Park Opens Phase 2B Randomized Clinical Trial of Promising Brain Cancer Immunotherapy

Roswell Park Opens Phase 2B Randomized Clinical Trial of Promising Brain Cancer Immunotherapy

Roswell Park Opens Phase 2B Randomized Clinical Trial of Promising Brain Cancer Immunotherapy

Roswell Park Opens Phase 2B Randomized Clinical Trial of Promising Brain Cancer Immunotherapy

Showing 1 - 12 of 14 results

Previous| 1 | 2 |Next

BROADCASTMED
BroadcastMed Privacy Policy

Medical Disclaimer